More diverse investigators could help diversify clinical trials | Cornell ChronicleBlack Americans trust Black doctors more in medical studies, leading to better enrollment in clinical trials.
4.75m NHS research centre to bring cutting-edge treatments to east LondonThe new research center will accelerate access to advanced treatments for patients in east London.
Neuralink gets approval to start human trials in CanadaNeuralink will conduct its first human clinical trials in Canada, focusing on brain-computer interface technology.
Starmer pledges to slash time needed to set up clinical trials to 150 daysQuality journalism should be accessible to all, fostering factual reporting amidst political challenges.
Bay Area biotech firm once worth $13B lays off all but 15 workersAllakos announces failure of pivotal clinical trial for chronic hives drug AK006, resulting in a 75% staff layoff.
Delft-based OASYS NOW wins Slush 100 competition - Silicon CanalsOASYS NOW is revolutionizing patient recruitment for clinical trials with an AI-powered platform, potentially saving lives and enhancing drug development efficiency.
More diverse investigators could help diversify clinical trials | Cornell ChronicleBlack Americans trust Black doctors more in medical studies, leading to better enrollment in clinical trials.
4.75m NHS research centre to bring cutting-edge treatments to east LondonThe new research center will accelerate access to advanced treatments for patients in east London.
Neuralink gets approval to start human trials in CanadaNeuralink will conduct its first human clinical trials in Canada, focusing on brain-computer interface technology.
Starmer pledges to slash time needed to set up clinical trials to 150 daysQuality journalism should be accessible to all, fostering factual reporting amidst political challenges.
Bay Area biotech firm once worth $13B lays off all but 15 workersAllakos announces failure of pivotal clinical trial for chronic hives drug AK006, resulting in a 75% staff layoff.
Delft-based OASYS NOW wins Slush 100 competition - Silicon CanalsOASYS NOW is revolutionizing patient recruitment for clinical trials with an AI-powered platform, potentially saving lives and enhancing drug development efficiency.
The (artificial intelligence) therapist can see you nowAI bots can deliver effective mental health therapy, matching human clinicians' efficacy.
How an Activist Group Helped Torpedo MDMA TherapyLykos Therapeutics faces scrutiny for its MDMA treatment for PTSD after accusations of misconduct and abuse, challenging its FDA application process.
Grasping for hope: The heartbreaking journey through Alzheimer's drug trialsJohn's emotional journey with Cheryl highlights the complexity of caring for a loved one with Alzheimer's and the search for effective treatments.
Study reveals the limited research on ADHD treatments for adultsADHD is often misperceived as a childhood disorder, leading to limited treatment options for adults suffering from it.
A new $25M fund aims to give UK mental health startups a shot in the arm | TechCrunchKHP Ventures is launching a £20 million fund to support mental health startups addressing depression, anxiety, and psychosis, in collaboration with major healthcare providers.
Psychedelic experiences in clinical settings | LettersPsychedelic experiences may be negatively impacted by clinical environments; diversity and informed consent in trials are crucial.
The (artificial intelligence) therapist can see you nowAI bots can deliver effective mental health therapy, matching human clinicians' efficacy.
How an Activist Group Helped Torpedo MDMA TherapyLykos Therapeutics faces scrutiny for its MDMA treatment for PTSD after accusations of misconduct and abuse, challenging its FDA application process.
Grasping for hope: The heartbreaking journey through Alzheimer's drug trialsJohn's emotional journey with Cheryl highlights the complexity of caring for a loved one with Alzheimer's and the search for effective treatments.
Study reveals the limited research on ADHD treatments for adultsADHD is often misperceived as a childhood disorder, leading to limited treatment options for adults suffering from it.
A new $25M fund aims to give UK mental health startups a shot in the arm | TechCrunchKHP Ventures is launching a £20 million fund to support mental health startups addressing depression, anxiety, and psychosis, in collaboration with major healthcare providers.
Psychedelic experiences in clinical settings | LettersPsychedelic experiences may be negatively impacted by clinical environments; diversity and informed consent in trials are crucial.
Finland's Valo Therapeutics bags 19M in fundingValo Therapeutics raises €19M for innovative immunotherapy development targeting cancer with a novel technology.
TIL therapy for metastatic gastrointestinal cancersA new TIL therapy shows promise for treating metastatic gastrointestinal cancers and may extend to other solid tumors.
Finland's Valo Therapeutics bags 19M in fundingValo Therapeutics raises €19M for innovative immunotherapy development targeting cancer with a novel technology.
TIL therapy for metastatic gastrointestinal cancersA new TIL therapy shows promise for treating metastatic gastrointestinal cancers and may extend to other solid tumors.
Google DeepMind Launches TxGemma: Advancing AI-Driven Drug Discovery and DevelopmentTxGemma, an AI model from Google DeepMind, aims to accelerate drug discovery and clinical trials by improving prediction efficiency.
Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive | TechCrunchIsomorphic Labs has raised $600 million to enhance its AI drug discovery efforts and support clinical trials.
Google DeepMind Launches TxGemma: Advancing AI-Driven Drug Discovery and DevelopmentTxGemma, an AI model from Google DeepMind, aims to accelerate drug discovery and clinical trials by improving prediction efficiency.
Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive | TechCrunchIsomorphic Labs has raised $600 million to enhance its AI drug discovery efforts and support clinical trials.
The future of neuroscience could be wirelessWireless brain-computer interface technology advanced during the pandemic, allowing research to continue and participants to engage remotely.
Paralyzed Man Standing, Learning to Walk Again After Injection of Hacked Stem CellsStem cell treatment allows a paralyzed man to stand again after spinal cord injury.
Synchron's Brain-Computer Interface Now Has Nvidia's AISynchron's tech allows non-invasive brain-computer interface development, enabling data collection for AI models using avatars as time stamps.
The future of neuroscience could be wirelessWireless brain-computer interface technology advanced during the pandemic, allowing research to continue and participants to engage remotely.
Paralyzed Man Standing, Learning to Walk Again After Injection of Hacked Stem CellsStem cell treatment allows a paralyzed man to stand again after spinal cord injury.
Synchron's Brain-Computer Interface Now Has Nvidia's AISynchron's tech allows non-invasive brain-computer interface development, enabling data collection for AI models using avatars as time stamps.
Lower Back Pain Drug Shows Promising ResultsPP353 is a promising non-opioid treatment for chronic lower back pain, showing significant improvement in clinical trials.
Sperm Stem Cells Were Used for the First Time in an Attempt to Restore FertilityThe initial transplant demonstrated safety, with normal hormone levels and no harm to testicular tissue, though sperm is still absent.
UK life sciences losing 15bn a year to global rivalsThe UK's life sciences sector is losing £15 billion annually due to reduced investment and exports.
Elon Musk chooses Miami for Neuralink brain-implant researchNeuralink launches clinical trials in Miami to test brain-computer interfaces for patients with paralysis.
Neuralink has selected its next U.S. location for ongoing PRIME studyNeuralink expands its brain-computer interface study to the University of Miami to help individuals with quadriplegia.
Neuralink brain trials head for CanadaNeuralink is recruiting participants for its neurotech trial, aiming to enable computer control through thought.The study targets individuals with severe motor impairments due to spinal injuries or ALS.
Cognixion Axon-R Headset Tackles ALS Communication Challenges - Yanko DesignCognixion's Axon-R headset aims to restore communication abilities in late-stage ALS patients through innovative brain-computer interface technology.
Elon Musk's Neuralink to launch new brain-implant trial involving robotic armNeuralink is advancing trials for its brain-computer interface to assist individuals with quadriplegia through direct thought control of devices.
Elon Musk chooses Miami for Neuralink brain-implant researchNeuralink launches clinical trials in Miami to test brain-computer interfaces for patients with paralysis.
Neuralink has selected its next U.S. location for ongoing PRIME studyNeuralink expands its brain-computer interface study to the University of Miami to help individuals with quadriplegia.
Neuralink brain trials head for CanadaNeuralink is recruiting participants for its neurotech trial, aiming to enable computer control through thought.The study targets individuals with severe motor impairments due to spinal injuries or ALS.
Cognixion Axon-R Headset Tackles ALS Communication Challenges - Yanko DesignCognixion's Axon-R headset aims to restore communication abilities in late-stage ALS patients through innovative brain-computer interface technology.
Elon Musk's Neuralink to launch new brain-implant trial involving robotic armNeuralink is advancing trials for its brain-computer interface to assist individuals with quadriplegia through direct thought control of devices.
Stem cells head to the clinic: treatments for cancer, diabetes and Parkinson's disease could soon be herePatient participation in clinical trials enhances understanding and treatment of debilitating diseases, exemplified by Andrew Cassy's involvement after his Parkinson's diagnosis.
New Form of Parkinson's Treatment Uses Real-Time Deep-Brain StimulationDeep-brain stimulation technology has dramatically improved symptoms for Parkinson's patients, reducing medication and enhancing quality of life.
Relative of Ozempic Failed to Treat Parkinson's Disease in TrialRecent study shows GLP-1 drugs aren't effective for treating or slowing progression of Parkinson's disease.
Stem cells head to the clinic: treatments for cancer, diabetes and Parkinson's disease could soon be herePatient participation in clinical trials enhances understanding and treatment of debilitating diseases, exemplified by Andrew Cassy's involvement after his Parkinson's diagnosis.
New Form of Parkinson's Treatment Uses Real-Time Deep-Brain StimulationDeep-brain stimulation technology has dramatically improved symptoms for Parkinson's patients, reducing medication and enhancing quality of life.
Relative of Ozempic Failed to Treat Parkinson's Disease in TrialRecent study shows GLP-1 drugs aren't effective for treating or slowing progression of Parkinson's disease.
Man with artificial heart survives 100 days outside hospitalBiVACOR's Total Artificial Heart successfully supported a patient for over 100 days before he received a transplant.
Sweden's Acorai bags 4.2M to advance heart failure management devicesAcorai secures $4.5M funding for its heart failure management device and aims for market launch by 2026.
Dublin-based FIRE1 secures 115M to help patients suffering from chronic diseases - Silicon CanalsFIRE1 secured $120M to advance heart failure management technology through clinical trials and FDA recognition.
Man with artificial heart survives 100 days outside hospitalBiVACOR's Total Artificial Heart successfully supported a patient for over 100 days before he received a transplant.
Sweden's Acorai bags 4.2M to advance heart failure management devicesAcorai secures $4.5M funding for its heart failure management device and aims for market launch by 2026.
Dublin-based FIRE1 secures 115M to help patients suffering from chronic diseases - Silicon CanalsFIRE1 secured $120M to advance heart failure management technology through clinical trials and FDA recognition.
Chaos at the V.A.: Inside the DOGE Cuts Disrupting the Veterans AgencyBudget cuts at the V.A. have disrupted critical cancer drug trials for veterans, halting essential research due to hiring freezes.
Three-pronged treatment improves prognosis for inoperable liver cancerCombining targeted therapies with traditional treatments enhances the fight against aggressive liver cancer, marking a significant therapeutic advancement.
The FDA pulls key DEI initiative for cancer studies from its websiteThe FDA has removed online resources related to diversity in clinical trials, affecting initiatives for inclusive drug evaluations.
Abrupt changes to NIH funding rules could disrupt cancer research clinical trialsCuts to indirect funding may disrupt essential cancer research and clinical trials, negatively impacting patient outcomes.
Orakl Oncology combines data and biology to bring new drugs to cancer patients | TechCrunchCancer incidence is increasing among younger adults, yet new drug trials often fail, highlighting the need for improved trial designs.
Bay Area biotech firm guts staff, shuts trial after dangerous side effectsCargo Therapeutics halts a clinical trial and lays off half its workforce due to poor results and the need to conserve cash.
Chaos at the V.A.: Inside the DOGE Cuts Disrupting the Veterans AgencyBudget cuts at the V.A. have disrupted critical cancer drug trials for veterans, halting essential research due to hiring freezes.
Three-pronged treatment improves prognosis for inoperable liver cancerCombining targeted therapies with traditional treatments enhances the fight against aggressive liver cancer, marking a significant therapeutic advancement.
The FDA pulls key DEI initiative for cancer studies from its websiteThe FDA has removed online resources related to diversity in clinical trials, affecting initiatives for inclusive drug evaluations.
Abrupt changes to NIH funding rules could disrupt cancer research clinical trialsCuts to indirect funding may disrupt essential cancer research and clinical trials, negatively impacting patient outcomes.
Orakl Oncology combines data and biology to bring new drugs to cancer patients | TechCrunchCancer incidence is increasing among younger adults, yet new drug trials often fail, highlighting the need for improved trial designs.
Bay Area biotech firm guts staff, shuts trial after dangerous side effectsCargo Therapeutics halts a clinical trial and lays off half its workforce due to poor results and the need to conserve cash.
How close are scientists to producing artificial blood?Artificial blood substitutes are being developed to address global blood shortages and improve transfusion safety.
Inside the Incredible Potential of Quantum Computing in Drug Development | HackerNoonQuantum computing has the potential to significantly accelerate drug development timelines, ultimately saving lives and reducing costs.
Will AI revolutionise drug development? Researchers say it depends on how it's usedAI in drug development shows promise but requires cautious optimism and realistic expectations.Despite excitement, AI has not yet significantly improved drug success rates in clinical trials.
Trial of Controversial Alzheimer's Drug Halted After Disappointing ResultsCassava Sciences halted the advanced trial for simufilam as it failed to reduce cognitive decline in Alzheimer's patients, disappointing many.
Big data and Google BigQuery improve cancer drug development by detecting bacteria | Computer WeeklyUnderstanding the relationship between bacteria and drug efficacy is crucial for improving cancer treatment and drug trial success rates.
Inside the Incredible Potential of Quantum Computing in Drug Development | HackerNoonQuantum computing has the potential to significantly accelerate drug development timelines, ultimately saving lives and reducing costs.
Will AI revolutionise drug development? Researchers say it depends on how it's usedAI in drug development shows promise but requires cautious optimism and realistic expectations.Despite excitement, AI has not yet significantly improved drug success rates in clinical trials.
Trial of Controversial Alzheimer's Drug Halted After Disappointing ResultsCassava Sciences halted the advanced trial for simufilam as it failed to reduce cognitive decline in Alzheimer's patients, disappointing many.
Big data and Google BigQuery improve cancer drug development by detecting bacteria | Computer WeeklyUnderstanding the relationship between bacteria and drug efficacy is crucial for improving cancer treatment and drug trial success rates.
Saliva that fights norovirus? Experimental oral vaccine is nothing to spit at.The experimental norovirus vaccine shows promise for older adults by generating effective immune responses where needed most.
Infectious Disease Expert Jennifer Jao to Help Lead AIDS Clinical-Trials Network - News CenterDr. Jennifer Jao has been appointed co-chair of the IMPAACT Network to enhance global HIV research for mothers and children.
Trump's early actions on health agencies roil medical researchersHHS halted communications and grant reviews, impacting vital health research and programs under the Trump administration.
Saliva that fights norovirus? Experimental oral vaccine is nothing to spit at.The experimental norovirus vaccine shows promise for older adults by generating effective immune responses where needed most.
Infectious Disease Expert Jennifer Jao to Help Lead AIDS Clinical-Trials Network - News CenterDr. Jennifer Jao has been appointed co-chair of the IMPAACT Network to enhance global HIV research for mothers and children.
Trump's early actions on health agencies roil medical researchersHHS halted communications and grant reviews, impacting vital health research and programs under the Trump administration.
Restoring vision with optogeneticsRobin McCoy is participating in a clinical trial for optogenetic therapy to combat her inherited retinitis pigmentosa.
How can treatment for eye disease be made easier?The approval of ranibizumab in 2006 significantly improved outcomes for wet AMD patients, but real-world treatment adherence remains a challenge.
Halted research, disciplined doctors: internal audit finds Kaiser ignored patient protections in Northern California studyKaiser Permanente researchers violated volunteer trust, breaching safety protocols in a clinical trial, leading to its termination and disciplinary actions.
Patients Are Dying After a Strange Cancer Treatment on a Remote IslandThe ExThera device claimed to treat cancer but had serious health risks, highlighting the need for regulatory oversight in medical treatments.
Puberty blockers: Can a drug trial solve one of medicine's most controversial debates?The benefits and harms of puberty blockers for children seeking gender treatment are hotly debated and require careful clinical evaluation.
Lies...Still the Best Medicine?Placebo surgeries prompt a significant ethical debate about deception in medical practice despite their potential benefits.
Halted research, disciplined doctors: internal audit finds Kaiser ignored patient protections in Northern California studyKaiser Permanente researchers violated volunteer trust, breaching safety protocols in a clinical trial, leading to its termination and disciplinary actions.
Patients Are Dying After a Strange Cancer Treatment on a Remote IslandThe ExThera device claimed to treat cancer but had serious health risks, highlighting the need for regulatory oversight in medical treatments.
Puberty blockers: Can a drug trial solve one of medicine's most controversial debates?The benefits and harms of puberty blockers for children seeking gender treatment are hotly debated and require careful clinical evaluation.
Lies...Still the Best Medicine?Placebo surgeries prompt a significant ethical debate about deception in medical practice despite their potential benefits.
Dozens of new obesity drugs are coming: these are the ones to watchCook's experience underscores the emerging treatment strategies for obesity, focusing on Appetite suppression and muscle preservation.
Alzheimer's was taking her memory, so she started taking a new drugDrugs like Kisunla may slow Alzheimer's, allowing some patients to maintain daily activities despite the disease.
Dozens of new obesity drugs are coming: these are the ones to watchCook's experience underscores the emerging treatment strategies for obesity, focusing on Appetite suppression and muscle preservation.
Alzheimer's was taking her memory, so she started taking a new drugDrugs like Kisunla may slow Alzheimer's, allowing some patients to maintain daily activities despite the disease.
Did an Alzheimer's drug give Sue and Ken Bell more time? MaybeLeqembi and Kisunla, new Alzheimer's drugs, can slow disease progression but do not restore memory or cognition.
Former Stanford research coordinator convicted of altering patient records in breast cancer studyA former Stanford employee was convicted of altering patient records in a breast cancer study after being dismissed from her position.
'Everybody cried when I was able to walk again'Claire Trivedi, paralyzed since 2017, took her first steps after pioneering spinal cord stimulation therapy, inspiring hope for spinal cord injury recovery.
Brain zapping allows partially paralysed patients to walkDeep brain stimulation has enabled partially paralysed patients to walk again, marking a significant advance for those with spinal cord injuries.
'Everybody cried when I was able to walk again'Claire Trivedi, paralyzed since 2017, took her first steps after pioneering spinal cord stimulation therapy, inspiring hope for spinal cord injury recovery.
Brain zapping allows partially paralysed patients to walkDeep brain stimulation has enabled partially paralysed patients to walk again, marking a significant advance for those with spinal cord injuries.
Microbiota Transplant Shows Promise for Colon Infections - News CenterMicrobiota transplantation shows promise as a safe and effective treatment for recurrent clostridioides difficile infections.
Snapshots of acyl carrier protein shuttling in human fatty acid synthase - NatureDe novo lipogenesis is crucial for mammalian development and metabolic health, particularly during disease states.Targeting the FASN enzyme shows therapeutic potential but requires careful consideration of its broader physiological effects.
A grim prognosis, a gamble and one patient's fight to defy cancerFacing a cancer prognosis can lead patients to choose between clinical trials and traditional treatments.
Snapshots of acyl carrier protein shuttling in human fatty acid synthase - NatureDe novo lipogenesis is crucial for mammalian development and metabolic health, particularly during disease states.Targeting the FASN enzyme shows therapeutic potential but requires careful consideration of its broader physiological effects.
A grim prognosis, a gamble and one patient's fight to defy cancerFacing a cancer prognosis can lead patients to choose between clinical trials and traditional treatments.
Woman in cancer remission for record 19 years after CAR-T immune treatmentCAR T-cell therapy has shown groundbreaking success, particularly for a girl with nerve-cell cancer who is now cancer-free after 19 years.
HERVolution Therapeutics Raises $11.7M Series A to Advance Dark Genome-Based Immunotherapies for Cancer and AgingHERVolution secures $11.7 million Series A funding to advance HERV-targeting immunotherapies.
Woman in cancer remission for record 19 years after CAR-T immune treatmentCAR T-cell therapy has shown groundbreaking success, particularly for a girl with nerve-cell cancer who is now cancer-free after 19 years.
HERVolution Therapeutics Raises $11.7M Series A to Advance Dark Genome-Based Immunotherapies for Cancer and AgingHERVolution secures $11.7 million Series A funding to advance HERV-targeting immunotherapies.
Ozempic helped people drink less alcohol in a major study - unlocking a whole new playground for drug developersOzempic may significantly reduce alcohol cravings and smoking behaviors, indicating potential as a treatment for alcohol use disorder.
Weight-loss jabs 'slash alcohol cravings and curb heavy drinking'Semaglutide significantly reduces alcohol consumption and desire, indicating potential benefits for treating alcohol use disorder.
Weight-loss jabs may help reduce alcohol intake, study findsWeight-loss medications like semaglutide can significantly reduce alcohol cravings and consumption in individuals with alcohol use disorder.
Ozempic helped people drink less alcohol in a major study - unlocking a whole new playground for drug developersOzempic may significantly reduce alcohol cravings and smoking behaviors, indicating potential as a treatment for alcohol use disorder.
Weight-loss jabs 'slash alcohol cravings and curb heavy drinking'Semaglutide significantly reduces alcohol consumption and desire, indicating potential benefits for treating alcohol use disorder.
Weight-loss jabs may help reduce alcohol intake, study findsWeight-loss medications like semaglutide can significantly reduce alcohol cravings and consumption in individuals with alcohol use disorder.
Animal-to-Human Organ Transplants Hit Long-Awaited Testing MilestoneThe first clinical trial for genetically modified pig kidney transplants has been approved, offering new hope for transplant patients.
Surgeons Transplant Engineered Pig Kidney Into Fourth PatientSuccessful genetically modified pig kidney transplant performed on a 66-year-old man raises hopes for addressing organ shortages.
Animal-to-Human Organ Transplants Hit Long-Awaited Testing MilestoneThe first clinical trial for genetically modified pig kidney transplants has been approved, offering new hope for transplant patients.
Surgeons Transplant Engineered Pig Kidney Into Fourth PatientSuccessful genetically modified pig kidney transplant performed on a 66-year-old man raises hopes for addressing organ shortages.
Pfizer Vaccine Trial Exposed: What They Didn't Want You to KnowPfizer concealed severe adverse effects of its COVID vaccine trial on children, significantly impacting parental decisions regarding vaccination.
New treatment for hair loss shows promise - paid volunteers needed to test it outVDPHL01 is a promising non-hormonal treatment for male pattern baldness undergoing clinical trials.
Dozens of Clinical Trials Have Been Frozen in Response to Trump's USAID OrderThe abrupt halt of funding for medical trials by the Trump administration leaves participants at risk and raises ethical concerns.
The science behind the first pig-organ transplant trial in humansThe FDA has approved a trial for pig kidney transplantation in humans, marking a significant step towards alleviating organ donor shortages.
F.D.A. Approves Studies of Pig Organ Transplants for Kidney PatientsFDA approves clinical trials for organ transplants from genetically modified pigs, marking a significant advancement in cross-species transplantation.
Brand-new painkiller approved by US health agency DW 01/31/2025Suzetrigine, a new painkiller, offers relief without the addictive potential of opioids, marking a significant advancement in pain management.
What Is Journavx, the New Opioid-Free Painkiller from Vertex?Suzetrigine is a groundbreaking painkiller approved by the FDA, providing an effective alternative to opioids without addiction risks.
The science behind the first pig-organ transplant trial in humansThe FDA has approved a trial for pig kidney transplantation in humans, marking a significant step towards alleviating organ donor shortages.
F.D.A. Approves Studies of Pig Organ Transplants for Kidney PatientsFDA approves clinical trials for organ transplants from genetically modified pigs, marking a significant advancement in cross-species transplantation.
Brand-new painkiller approved by US health agency DW 01/31/2025Suzetrigine, a new painkiller, offers relief without the addictive potential of opioids, marking a significant advancement in pain management.
What Is Journavx, the New Opioid-Free Painkiller from Vertex?Suzetrigine is a groundbreaking painkiller approved by the FDA, providing an effective alternative to opioids without addiction risks.
Scientists Record Breakthrough in Treating Cancer With a VirusOncolytic virus therapy shows promise for treating cancer by enhancing the immune system's response to tumors.
Combination Therapy Improves Outcomes for Rare Blood Disorder - News CenterCombination treatment of danicopan with C5 inhibitors shows promise in improving anemia in PNH patients resistant to previous therapies.
Clinical Trials Underway for Dozens of New Stem Cell TreatmentsStem cell treatments are emerging as potential therapies for a variety of conditions, especially neurological disorders.
Scientists Record Breakthrough in Treating Cancer With a VirusOncolytic virus therapy shows promise for treating cancer by enhancing the immune system's response to tumors.
Combination Therapy Improves Outcomes for Rare Blood Disorder - News CenterCombination treatment of danicopan with C5 inhibitors shows promise in improving anemia in PNH patients resistant to previous therapies.
Clinical Trials Underway for Dozens of New Stem Cell TreatmentsStem cell treatments are emerging as potential therapies for a variety of conditions, especially neurological disorders.
DeepMind CEO expects we'll pop AI-generated pills in 2025AI-designed drugs could enter clinical trials by the end of the year, potentially transforming drug development.
Lindus Health raises $55M to 'fix the broken clinical trial industry' | TechCrunchLindus Health is transforming clinical trials through automation and machine learning to accelerate drug development.The company has raised $55 million to advance its mission in the growing CRO market.
DeepMind CEO expects we'll pop AI-generated pills in 2025AI-designed drugs could enter clinical trials by the end of the year, potentially transforming drug development.
Lindus Health raises $55M to 'fix the broken clinical trial industry' | TechCrunchLindus Health is transforming clinical trials through automation and machine learning to accelerate drug development.The company has raised $55 million to advance its mission in the growing CRO market.
Europe accelerates AI drug discovery as DeepMind spinoff targets trials this yearIsomorphic Labs aims to start clinical trials for AI-designed drugs by the end of this year.
Bay Area biotech firm once worth billions guts staff with 73% layoffIGM Biosciences lays off 73% of staff due to poor clinical study results and aims to preserve cash amid ongoing research challenges.
Struggling Bay Area biotech firm, once worth $1B, lays off almost entire staffKronos Bio is undergoing major layoffs and has discontinued its only clinical drug due to adverse effects.
Bay Area biotech firm once worth billions guts staff with 73% layoffIGM Biosciences lays off 73% of staff due to poor clinical study results and aims to preserve cash amid ongoing research challenges.
Struggling Bay Area biotech firm, once worth $1B, lays off almost entire staffKronos Bio is undergoing major layoffs and has discontinued its only clinical drug due to adverse effects.
Grove cuts clinical trial enrollment time with AI | TechCrunchGrove AI leverages generative AI to streamline clinical trial enrollment, reducing a lengthy process to mere minutes.
Developer Kirill Sergeev Speaks on Empowering Healthcare System with Latest AI-solutions | HackerNoonThe growing demand for real-time insights in healthcare is driving the need for advanced data solutions, projected to reach $45 billion by 2027.
Grove cuts clinical trial enrollment time with AI | TechCrunchGrove AI leverages generative AI to streamline clinical trial enrollment, reducing a lengthy process to mere minutes.
Developer Kirill Sergeev Speaks on Empowering Healthcare System with Latest AI-solutions | HackerNoonThe growing demand for real-time insights in healthcare is driving the need for advanced data solutions, projected to reach $45 billion by 2027.
New Amgen Drug MariTide Shows Promising Weight Loss in Early DataAmgen's experimental obesity drug MariTide shows promise with an average weight loss of up to 20% over a year, pending further trials.
'Natural Ozempic' capsules may reduce appetite and calorie intake - but they're not available in the US yetElcella is a low-cost natural supplement aimed at reducing appetite without side effects, unlike some weight loss injections.The supplement promotes the release of natural appetite-suppressing hormones instead of synthetic alternatives.
New Amgen Drug MariTide Shows Promising Weight Loss in Early DataAmgen's experimental obesity drug MariTide shows promise with an average weight loss of up to 20% over a year, pending further trials.
'Natural Ozempic' capsules may reduce appetite and calorie intake - but they're not available in the US yetElcella is a low-cost natural supplement aimed at reducing appetite without side effects, unlike some weight loss injections.The supplement promotes the release of natural appetite-suppressing hormones instead of synthetic alternatives.
Novo Nordisk stock price takes a tumble after the Wegovy maker's next-generation weight-loss drug underwhelmsCagriSema failed to meet weight loss expectations in trials, causing significant stock decline for Novo Nordisk.
Blood Test May Reduce Unnecessary Prostate Cancer Biopsies - News CenterA new blood test can accurately detect prostate cancer and reduce unnecessary biopsies across diverse racial and ethnic groups.
U.K. Bans Puberty Blockers for Teens IndefinitelyThe UK is indefinitely banning puberty blockers for under-18s with gender dysphoria, except in clinical trials, due to safety concerns.
Puberty blockers to be banned indefinitely for under-18s across UKPuberty blockers for under-18s with gender dysphoria will be banned indefinitely in the UK, except in clinical trials.
U.K. Bans Puberty Blockers for Teens IndefinitelyThe UK is indefinitely banning puberty blockers for under-18s with gender dysphoria, except in clinical trials, due to safety concerns.
Puberty blockers to be banned indefinitely for under-18s across UKPuberty blockers for under-18s with gender dysphoria will be banned indefinitely in the UK, except in clinical trials.
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours - NatureGDF-15 targeting may improve cancer treatment efficacy alongside existing anti-PD-1 therapies.Clinical trials indicate the potential of visugromab in overcoming immune escape mechanisms in tumours.
What to Know About Vagus Nerve Stimulation for IBDVagus nerve stimulation significantly improved Joseph Beinlich's ulcerative colitis symptoms, enhancing his quality of life and daily functioning.
Cleerly raises $106M from Insight Partners for AI heart health early detection | TechCrunchCleerly's AI seeks to identify heart disease early, addressing a significant gap in awareness and treatment for asymptomatic individuals.
Drug, now in testing, has promise for epileptic seizuresBHV-7000 offers hope for treating drug-resistant seizures by activating potassium receptors, a new avenue for epilepsy treatment with minimal side effects.
Improving the Treatment of Valvular Heart Diseases - News CenterNonsurgical transcatheter heart valve replacement enhances patient outcomes in severe aortic stenosis versus standard care.
Cassava Sciences update: SAVA stock price collapses after much-criticized Alzheimer's drug flopsCassava Sciences' Alzheimer's drug simufilam failed its Phase 3 trials, leading to halted further trials and a significant plummet in stock value.
Elon Musk's Neuralink gets first-ever approval outside of U.S.Neuralink receives approval for its first clinical trial in Canada, aiming to assess its brain implant's safety and functionality for treating paralysis and mental health disorders.